2013
DOI: 10.1371/journal.pntd.0002080
|View full text |Cite
|
Sign up to set email alerts
|

A Success Story: Togo Is Moving toward Becoming the First Sub-Saharan African Nation to Eliminate Lymphatic Filariasis through Mass Drug Administration and Countrywide Morbidity Alleviation

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

2
70
0

Year Published

2013
2013
2024
2024

Publication Types

Select...
6
2
1

Relationship

1
8

Authors

Journals

citations
Cited by 51 publications
(72 citation statements)
references
References 19 publications
2
70
0
Order By: Relevance
“…Although the current report focuses on surveillance to ensure interruption of transmission, morbidity control efforts have also been an essential component of the LF control program in Togo and have recently been described elsewhere. 6,24 Because hydrocele and lymphedema are poor indicators of active filarial burden, 25 they are not currently used for surveillance of LF transmission in Togo; incorporation of these indicators of LF-related morbidity into ongoing surveillance should be considered.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Although the current report focuses on surveillance to ensure interruption of transmission, morbidity control efforts have also been an essential component of the LF control program in Togo and have recently been described elsewhere. 6,24 Because hydrocele and lymphedema are poor indicators of active filarial burden, 25 they are not currently used for surveillance of LF transmission in Togo; incorporation of these indicators of LF-related morbidity into ongoing surveillance should be considered.…”
Section: Discussionmentioning
confidence: 99%
“…Seven of the country's thirty-five medical districts were LF-endemic before onset of MDA in 2000; the last MDA in Togo was conducted in 2009. 6 A nationwide laboratory-based LF surveillance system, developed in cooperation with the US Centers for Disease Control and Prevention (CDC), covering all 35 districts and designed to be sustainable in resource-poor settings was implemented in 2006 and has been described in detail in the work by Mathieu and others. 7 The technicians in this laboratory-based surveillance system review nocturnal malarial thick blood smears collected from patients at district hospitals (or equivalent inpatient facilities) throughout the country for the presence of microfilariae.…”
Section: Introductionmentioning
confidence: 99%
“…The main intervention strategy is mass drug administration (MDA) with albendazole in combination with diethylcarbamazine (DEC) (or ivermectin in countries where onchocerciasis is endemic) to entire communities in districts where the prevalence of LF is equal or more than 1% [6], supported by vector control to reduce exposure to mosquitoes and morbidity management to alleviate suffering and prevent disability of those affected by the disease [7,8]. During the last half century, several countries have successfully eliminated LF, including Japan, China, South Korea, the Solomon Islands, Egypt and Togo [9][10][11][12][13].…”
Section: Introductionmentioning
confidence: 99%
“…This has prompted the accolade that the GPELF is a “best buy” among many global health expenditures. Both China and the Republic of Korea have since declared elimination of lymphatic filariasis, and Togo is probably the first sub-Saharan African nation to have interrupted transmission of lymphatic filariasis (Sodahlon et al, 2013). Haiti is close to eliminating filariasis http://www.cdc.gov/media/releases/2013/p0614-haiti-filariasis.html.…”
Section: Where We Stand With Control Of Some Major Groups Of Human Hementioning
confidence: 99%